155 related articles for article (PubMed ID: 16869760)
21. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
22. Impact of EGFR mutation analysis in non-small cell lung cancer.
Yamamoto H; Toyooka S; Mitsudomi T
Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
[TBL] [Abstract][Full Text] [Related]
23. Mouse models of lung cancer.
Dutt A; Wong KK
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4396s-4402s. PubMed ID: 16857817
[TBL] [Abstract][Full Text] [Related]
24. Modeling human lung cancer in mice: similarities and shortcomings.
Tuveson DA; Jacks T
Oncogene; 1999 Sep; 18(38):5318-24. PubMed ID: 10498884
[TBL] [Abstract][Full Text] [Related]
25. Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.
Calbó J; Meuwissen R; van Montfort E; van Tellingen O; Berns A
Cold Spring Harb Symp Quant Biol; 2005; 70():225-32. PubMed ID: 16869758
[TBL] [Abstract][Full Text] [Related]
26. Grg1 acts as a lung-specific oncogene in a transgenic mouse model.
Allen T; van Tuyl M; Iyengar P; Jothy S; Post M; Tsao MS; Lobe CG
Cancer Res; 2006 Feb; 66(3):1294-301. PubMed ID: 16452182
[TBL] [Abstract][Full Text] [Related]
27. Stem cells for lung cancer?
Berns A
Cell; 2005 Jun; 121(6):811-3. PubMed ID: 15960966
[TBL] [Abstract][Full Text] [Related]
28. [The mouse as preclinical models of lung cancer].
Francoz S; Mathiaux J; Dubus P
Bull Cancer; 2012 Nov; 99(11):1017-27. PubMed ID: 23131302
[TBL] [Abstract][Full Text] [Related]
29. Future of early detection of lung cancer: the role of mouse models.
Shaw AT; Kirsch DG; Jacks T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4999s-5003s. PubMed ID: 16000603
[TBL] [Abstract][Full Text] [Related]
30. Progress and applications of mouse models for human lung cancer.
de Seranno S; Meuwissen R
Eur Respir J; 2010 Feb; 35(2):426-43. PubMed ID: 20123848
[TBL] [Abstract][Full Text] [Related]
31. Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention.
Parada LF; Kwon CH; Zhu Y
Cold Spring Harb Symp Quant Biol; 2005; 70():173-6. PubMed ID: 16869751
[TBL] [Abstract][Full Text] [Related]
32. New approaches for modelling cancer mechanisms in the mouse.
Maddison K; Clarke AR
J Pathol; 2005 Jan; 205(2):181-93. PubMed ID: 15641017
[TBL] [Abstract][Full Text] [Related]
33. Multigene mutation analysis on cytologic samples.
Fleury-Feith J; Gounant V; Lacave R; Cadranel J; Bernaudin JF
Chest; 2011 Dec; 140(6):1664. PubMed ID: 22147827
[No Abstract] [Full Text] [Related]
34. Cancer. Improved mouse models.
Berns A
Nature; 2001 Apr; 410(6832):1043-4. PubMed ID: 11323655
[No Abstract] [Full Text] [Related]
35. Forty years of cancer modelling in the mouse.
Hirst GL; Balmain A
Eur J Cancer; 2004 Sep; 40(13):1974-80. PubMed ID: 15315806
[TBL] [Abstract][Full Text] [Related]
36. An overview of lung cancer genomics and proteomics.
Granville CA; Dennis PA
Am J Respir Cell Mol Biol; 2005 Mar; 32(3):169-76. PubMed ID: 15713815
[TBL] [Abstract][Full Text] [Related]
37. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
Roth JA
Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520
[No Abstract] [Full Text] [Related]
38. Biology of lung cancer with implications for new therapies.
Aberle MF; McLeskey SW
Oncol Nurs Forum; 2003; 30(2):273-80. PubMed ID: 12692661
[TBL] [Abstract][Full Text] [Related]
39. From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma.
Ileana EE; Wistuba II; Izzo JG
Cancer J; 2015; 21(5):413-24. PubMed ID: 26389767
[TBL] [Abstract][Full Text] [Related]
40. Conditional mouse models of sporadic cancer.
Jonkers J; Berns A
Nat Rev Cancer; 2002 Apr; 2(4):251-65. PubMed ID: 12001987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
